CervoMed Inc. filed its 424B3 on Jul 13, 2023 for the period ending Dec 31, 2022. In this report its auditor, RSM & Co., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.45 USD | -0.85% | +0.49% | +220.45% |
Apr. 08 | Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating | MT |
Mar. 29 | CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+220.45% | 202M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.85% | 21.93B | |
-12.15% | 22.34B | |
-5.20% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CRVO Stock
- News CervoMed Inc.
- CervoMed Inc. Auditor Raises 'Going Concern' Doubt